Robert DiLuccio
17Patents
7h-index
19Co-inventors
63Inventor score
Filing activity: May 21, 1982 → Dec 23, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4626539A | Trandermal delivery of opioids | Human Necessities | 191 | Expired |
| US6551607B1 | Method for sequestration of skin irritants with substrate compositions | Human Necessities | 33 | Expired |
| US6521241B1 | Substrate composition for sequestration of skin irritants | Human Necessities | 30 | Expired |
| US4416942A | Laminates of lamellar articles and polyolefins | Emerging Cross-Sectional Technologies | 29 | Expired |
| US6485733B1 | Absorbent article composition for sequestering skin irritants | Human Necessities | 16 | Expired |
| US6656168B2 | Feminine care product with discrete areas of a skin wellness additive | Human Necessities | 14 | Expired |
| US6517848B1 | Method for sequestration of skin irritants with absorbent article composition | Human Necessities | 8 | Expired |
| US10517984B2 | Antimicrobial wound closure materials, including antimicrobial sutures, and method for closing a wound using the same | Emerging Cross-Sectional Technologies | 1 | Active |
| US12053478B2 | Taurultam, taurinamide and methylene glycol treatment for MYC—expressing tumors in mammalian bodies | Human Necessities | 0 | Active |
| US9149559B2 | Antimicrobial polymer compositions and the use thereof | Chemistry; Metallurgy | 0 | Active |
| US10478640B2 | Field sterilizer and vascular connector kit | Human Necessities | 0 | Active |
| US9149558B2 | Antimicrobial polymer compositions and the use thereof | Chemistry; Metallurgy | 0 | Active |
| US11541061B2 | Neuroblastoma treatment with taurolidine hydrolysis products | Human Necessities | 0 | Active |
| US8580307B2 | High glass transition temperature absorbable microspheres | Emerging Cross-Sectional Technologies | 0 | Active |
| US12302902B2 | Antimicrobial compositions, including antimicrobial hydrogels, effective against mature biofilms | Human Necessities | 0 | Active |
| US12016865B2 | Methods and pharmaceutical compositions for treating candida auris in blood | Human Necessities | 0 | Active |
| US9216142B2 | High-glass transition temperature absorbable microspheres | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.